2015年3月27日訊 /生物谷BIOON/ --智能藥丸(Smart Pills)是指內含微型傳感器,能自主在患者體內釋放藥物成分並通過信號反饋給患者的藥劑。而智能藥丸技術在複雜內窺鏡手術、藥物控制釋放、病人遠程監測等方面所展示出的誘人前景,也正在推動該技術在這些方面的應用和發展。目前,智能藥丸技術已越來越多地被全球醫療保健行業採用,以提高效率及消除內窺鏡檢測手術。
近日,美國市場研究機構Markets and Markets發布最新研究報告指出,全球智能藥丸市場在2014年市值15.6億美元,在未來10年(2014-2024),該市場將高速發展,2014-2020預測期內預計將以16.16%的年複合增長率(CAGR)增長,到2020年達到38.3億美元;而在2020-2024年,該市場將進一步高速發展,CAGR將達到23.7%,並在2024年達到89.8億美元。
各國政府對採用膠囊內窺鏡的有利報銷政策、患者對迷你微創手術的偏好、內窺手術的技術進步、胃腸道癌症發病率的上升,是推動全球智能藥丸市場發展的有利因素。此外,智能藥丸技術所提供的益處,如內窺鏡手術、靶向藥物遞送、簡化患者遠程監測方面的技術進步,也推動了這項技術的採用。然而,當前該領域仍存在著一些發展障礙,如膠囊內窺鏡技術的不成熟、高成本、患者吞咽晶片的恐懼心理,制約著全球智能藥丸市場的發展。
根據應用劃分,智能藥丸市場可細分為膠囊內窺鏡、藥物遞送、病人監測;其中,膠囊內窺鏡細分市場佔據了最大的市場份額。
根據地域劃分,全球智能藥丸市場可細分為北美、歐洲、亞洲、世界其他地區(RoW);其中,北美佔據了最大的市場份額,有利的報銷政策、FDA對智能藥丸的批准、政府及其他機構對智能藥丸投資的增長,是推動該地區智能藥丸市場高速增長的有利因素。亞洲是一個較新的市場,然而,一些國家(如日本)報銷政策的有利變化、相關企業的投資、內窺鏡研究的支持將推動該地區市場高速發展。
報告指出,全球智能藥丸市場的主要參與者包括:CapsoVision公司(美國)、Given Imaging公司(以色列)、Medimetrics SA de C.V.(墨西哥)、奧林巴斯公司(日本)、Bio-Images公司(英國)。
英文原文:Global Smart Pills Market Worth $8.98 Billion by 2024
DALLAS, March 25, 2015 /PRNewswire/ --
According to a new market research report "Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), by Target Area (Esophagus, Stomach, Small Intestine, Large Intestine), by Geography - Global Forecast to 2024 ", published by MarketsandMarkets, the Smart Pills Market is expected to reach around $8.98 Billion by 2024, growing at a CAGR of 16.16% 2014 - 2020 & CAGR of 23.7% 2020 - 2024.
Browse 67 market data Tables and 29 Figures spread through 200 Pages and in-depth TOC on "Smart Pills Market"
The Smart Pills Market is segmented on the basis of applications and regions. On the basis of applications, the market is categorized into capsule endoscopy, drug delivery, and patient monitoring. On the basis of regions, the market is divided into North America, Europe, Asia, and Rest of the World (RoW: Pacific countries, Africa, and Latin America)
The major factors driving the Smart Pills Market are favorable reimbursement scenario across the globe, patient preference for minimally invasive procedures, and rising prevalence of colon cancer. Moreover, benefits provided by the smart pills technology such as increased sophistication in endoscopy procedures, controlled drug delivery, and remote patient monitoring are resulting in the increasing adoption of smart pills technology. However, technological incompetence of capsule endoscopes, high costs, and fear among patients regarding swallowing a microchip are restraining the growth of this market.
The North American market commanded the largest share of the global Smart Pills Market in 2014. The Asian market, on the other hand, is relatively new, and the increasing reimbursements, training in endoscopes handling, and huge corporate investments in R&D in countries like Japan will drive the growth of this market.
The major players in the global Smart Pills Market are CapsoVision, Inc. (U.S.), Given Imaging, Inc. (Israel), Medimetrics S.A. de C.V. (Mexico), Olympus Corporation (Japan), and Bio-Images Research Limited (U.K.).